CLINICAL_TRIALS
withdrawal
· 2013-03-19
Clinical Trial Update: The Use of Domperidone for Gastroparesis [Phase 3]
Summary
A Phase 3 clinical trial evaluating domperidone for gastroparesis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allegiance Health | Conditions: Gastroparesis | Phase 3 | Status: WITHDRAWN